Thoratec (NSDQ:THOR) yesterday reported higher-than-forecast earnings for the 4th quarter and 2014, crediting an extra selling week and better utilization rates for its implantable heart pumps.
Q4
CareFusion crushes it in final quarter
BD beats Q1 estimates, raises outlook, shares jump
Edwards CFO Ullem: Share buybacks more likely than M&A
Boston Scientific’s Q4 profits slide 19%
(Reuters) — Medical device maker Boston Scientific (NYSE:BSX) posted a 19% fall in fourth-quarter profit as litigation charges more than doubled.